Pacira BioSciences Inc (PCRX)
26.81
+0.71
(+2.72%)
USD |
NASDAQ |
Apr 23, 16:00
26.80
-0.01
(-0.04%)
Pre-Market: 20:00
Pacira BioSciences Total Liabilities (Quarterly): 704.26M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 704.26M |
| September 30, 2023 | 702.91M |
| June 30, 2023 | 734.41M |
| March 31, 2023 | 755.38M |
| December 31, 2022 | 906.19M |
| September 30, 2022 | 964.24M |
| June 30, 2022 | 977.35M |
| March 31, 2022 | 1.182B |
| December 31, 2021 | 1.345B |
| September 30, 2021 | 637.40M |
| June 30, 2021 | 638.66M |
| March 31, 2021 | 636.73M |
| December 31, 2020 | 654.82M |
| September 30, 2020 | 635.58M |
| June 30, 2020 | 477.96M |
| March 31, 2020 | 447.34M |
| December 31, 2019 | 476.12M |
| September 30, 2019 | 461.33M |
| June 30, 2019 | 446.19M |
| March 31, 2019 | 391.64M |
| December 31, 2018 | 368.13M |
| September 30, 2018 | 357.78M |
| June 30, 2018 | 352.17M |
| March 31, 2018 | 343.52M |
| December 31, 2017 | 348.89M |
| Date | Value |
|---|---|
| September 30, 2017 | 341.29M |
| June 30, 2017 | 344.70M |
| March 31, 2017 | 329.33M |
| December 31, 2016 | 172.49M |
| September 30, 2016 | 167.00M |
| June 30, 2016 | 172.35M |
| March 31, 2016 | 165.04M |
| December 31, 2015 | 169.34M |
| September 30, 2015 | 159.98M |
| June 30, 2015 | 159.71M |
| March 31, 2015 | 151.01M |
| December 31, 2014 | 154.93M |
| September 30, 2014 | 150.32M |
| June 30, 2014 | 144.11M |
| March 31, 2014 | 127.98M |
| December 31, 2013 | 128.57M |
| September 30, 2013 | 123.28M |
| June 30, 2013 | 119.29M |
| March 31, 2013 | 115.45M |
| December 31, 2012 | 46.20M |
| September 30, 2012 | 52.38M |
| June 30, 2012 | 48.35M |
| March 31, 2012 | 57.02M |
| December 31, 2011 | 65.22M |
| September 30, 2011 | 63.73M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
446.19M
Minimum
Jun 2019
1.345B
Maximum
Dec 2021
725.46M
Average
654.82M
Median
Dec 2020
Total Liabilities (Quarterly) Benchmarks
| Dynavax Technologies Corp | 375.02M |
| Arbutus Biopharma Corp | 38.38M |
| Chimerix Inc | 19.74M |
| Karyopharm Therapeutics Inc | 376.64M |
| FibroGen Inc | 585.73M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.574B |
| Shareholders Equity (Quarterly) | 870.13M |
| Debt to Equity Ratio | 0.6004 |
| Current Ratio | 5.237 |
| Net Debt Paydown Yield | 2.87% |